<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiotomsk</journal-id><journal-title-group><journal-title xml:lang="ru">Сибирский журнал клинической и экспериментальной медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Siberian Journal of Clinical and Experimental Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2713-2927</issn><issn pub-type="epub">2713-265X</issn><publisher><publisher-name>TSU publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29001/2073-8552-2024-39-4-84-91</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiotomsk-2380</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL STUDIES</subject></subj-group></article-categories><title-group><article-title>FoxP3+ Т-регуляторные лимфоциты жировой ткани при различной выраженности коронарного атеросклероза у пациентов кардиохирургического профиля</article-title><trans-title-group xml:lang="en"><trans-title>FoxP3+ T-regulatory lymphocytes in adipose tissue of cardiac surgery patients with different severity of coronary atherosclerosis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6924-966X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дмитрюков</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Dmitriukov</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дмитрюков Алексей Александрович, младший научный сотрудник</p><p>634012, Томск, ул. Киевская, 111а</p></bio><bio xml:lang="en"><p>Alexey A. Dmitriukov, Junior Research Scientist, Clinical Diagnostic Laboratory</p><p>111a, Kievskaya str., Tomsk, 634012</p></bio><email xlink:type="simple">aldmn9k@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский институт кардиологии, Томский национальный исследовательский медицинский центр Российской академии наук (НИИ кардиологии Томского НИМЦ)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences (Cardiology Research Institute, Tomsk NRMC)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>30</day><month>12</month><year>2024</year></pub-date><volume>39</volume><issue>4</issue><issue-title>Выпуск 2024_4</issue-title><fpage>84</fpage><lpage>91</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Дмитрюков А.А., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Дмитрюков А.А.</copyright-holder><copyright-holder xml:lang="en">Dmitriukov A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.sibjcem.ru/jour/article/view/2380">https://www.sibjcem.ru/jour/article/view/2380</self-uri><abstract><sec><title>Введение</title><p>Введение. Т-регуляторные (T-reg) лимфоциты, как главные модуляторы иммунитета, присутствующие в эктопических очагах жировой ткани, могут участвовать в патогенезе атеросклероза. На сегодняшний день отсутствует информация о содержании T-reg лимфоцитов, в особенности в эпикардиальной (ЭЖТ) и тимусной жировой (ТЖТ) ткани у пациентов с коронарным атеросклерозом.</p></sec><sec><title>Цель работы</title><p>Цель работы. Изучить содержание FoxP3+ Т-регуляторных лимфоцитов периферической крови, эпикардиальной и тимусной жировой ткани у пациентов с коронарным атеросклерозом.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В исследование были включены 26 пациентов кардиохирургического профиля с коронарным атеросклерозом. Пациенты были поделены на 2 группы при помощи Gensini Score (GS): группу с выраженным коронарным атеросклерозом (GS&gt;26,5; n=15) и группу без выраженного коронарного атеросклероза (GS≤26,5; n=11). У всех пациентов методом проточной цитометрии с визуализацией определяли уровень ядерной транслокации FoxP3 и относительное содержание CD4+CD25hiFoxP3 и CD4+CD25loFoxP3 T-reg лимфоцитов в периферической крови, эпикардиальной, тимусной и подкожной жировой ткани (ПЖТ).</p></sec><sec><title>Результаты</title><p>Результаты. Группа пациентов с выраженным коронарным атеросклерозом характеризовалась повышенным относительным содержанием CD4+CD25hiFoxP3 Т-лимфоцитов (12,0 [6,5; 17,4] vs. 6,82 [3,32; 12,4] %; p=0,031) и пониженным уровнем ядерной транслокации FoxP3 CD4+CD25hiFoxP3 Т-лимфоцитов в ТЖТ (30,82 [18,50; 40,80] vs. 51,91 [25,9; 71,00] %; p=0,048). Выявлены корреляционные взаимосвязи между показателями FoxP3 T-reg лимфоцитов в различных жировых депо и показателями липидного спектра (ОХ, ХС-ЛВП). Обнаружены обратные корреляционные взаимосвязи между клетками ЭЖТ и ТЖТ, в частности, между относительным содержанием T-reg лимфоцитов и уровнем ядерной транслокации FoxP3.</p></sec><sec><title>Вывод</title><p>Вывод. Для пациентов с выраженным коронарным атеросклерозом (GS&gt;26,5 баллов) в тимусной жировой ткани характерно изменение иммунорегуляторного потенциала тимусной жировой ткани по сравнению с пациентами с умеренно выраженным атеросклерозом. Выявленные корреляционные взаимосвязи между относительным содержанием Т-reg лимфоцитов и уровнем ядерной транслокации FoxP3 в тимусной и эпикардиальной жировых тканях свидетельствуют о возможном существовании рециркуляции T-reg лимфоцитов между указанными эктопическими жировыми депо.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. T-regulatory (T-reg) lymphocytes as the main modulators of immunity, present in ectopic adipose tissue focuses, may be involved in the pathogenesis of atherosclerosis. Currently there is a lack of data regarding T-reg lymphocyte counts, particularly in epicardial (EAT) and thymic adipose tissue (TAT) in patients with coronary atherosclerosis.</p></sec><sec><title>Aim</title><p>Aim: To study the contents of FoxP3+ T-regulatory lymphocytes of peripheral blood, epicardial and thymic adipose tissue in patients with coronary atherosclerosis.</p></sec><sec><title>Materials and Methods</title><p>Materials and Methods. The study included a total of 26 cardiosurgical profile patients with coronary atherosclerosis. Patients were divided into two groups via Gensini Score (GS): first group with severe coronary atherosclerosis (GS &gt; 26.5; n = 15) and second group without severe coronary atherosclerosis (GS ≤ 26.5; n = 11). In all patients, the levels of FoxP3 nuclear translocation and the relative content of CD4+CD25hiFoxP3 and CD4+CD25loFoxP3 T-reg lymphocytes in peripheral blood, epicardial, thymic, and subcutaneous adipose tissue (SAT) were determined by flow cytometry with imaging.</p></sec><sec><title>Results</title><p>Results. The group of patients with severe coronary atherosclerosis was characterised by a statistically significant higher median of relative content of CD4+CD25hiFoxP3 T-lymphocytes (12.0 (6.5; 17.4) vs. 6.82 (3.32; 12.4) %; p = 0.031) and statistically significant lower median of nuclear translocation level of FoxP3 in CD4+CD25hiFoxP3 T-lymphocytes in TAT (30.82 (18.50; 40.80) vs. 51.91 (25.9; 71.00) %; p = 0.048). Statistically significant correlations between FoxP3 T-reg lymphocyte parameters in different adipose depots and lipid spectrum markers (TC, HDL-C) were found. There were inverse correlations found between EAT and TAT, in particular, between the relative contents of T-reg lymphocytes and of the FoxP3 nuclear translocation level.</p></sec><sec><title>Conclusion</title><p>Conclusion. Patients with severe coronary atherosclerosis (GS &gt; 26.5 points) were characterised by an increased relative content of CD4+CD25hiFoxP3 T-lymphocytes in thymic adipose tissue and a decreased level of FoxP3 nuclear translocation in this cell subpopulation compared to patients with moderate atherosclerosis (GS ≤ 26.5 points). Identified correlations between relative content of T-reg lymphocytes and the level of FoxP3 nuclear translocation in thymic and epicardial adipose tissues suggest potential existence of T-reg lymphocyte recirculation in-between these ectopic adipose depots.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>эпикардиальная жировая ткань</kwd><kwd>тимус</kwd><kwd>Т-регуляторные лимфоциты</kwd><kwd>FoxP3</kwd><kwd>субклеточная локализация</kwd><kwd>проточная цитометрия с визуализацией</kwd><kwd>коронарный атеросклероз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>epicardial adipose tissue</kwd><kwd>thymus</kwd><kwd>T-regulatory lymphocytes</kwd><kwd>FoxP3</kwd><kwd>subcellular localization</kwd><kwd>imaging flow cytometry</kwd><kwd>coronary atherosclerosis</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">работа выполнена в рамках фундаментального научного исследования № 122020300043–1.</funding-statement><funding-statement xml:lang="en">the study was performed in the framework of fundamental research No. 122020300043-1.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">AlZaim I., Hammoud S.H., Al-Koussa H. et al. Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases. J. Front. Cardiovasc. Med. 2020;7 17;7:1-40. DOI: 10.3389/fcvm.2020.602088.</mixed-citation><mixed-citation xml:lang="en">AlZaim I., Hammoud S.H., Al-Koussa H. et al. Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases. J. Front. Cardiovasc. Med. 2020;7 17;7:1-40. DOI: 10.3389/fcvm.2020.602088.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Napoli G., Pergola V., Basile P., De Feo D., Bertrandino F., Baggiano A. et al. Epicardial and Pericoronary Adipose Tissue, Coronary Inflammation, and Acute Coronary Syndromes. J. Clin. Med. 2023 21;12(23):7212. DOI: 10.3390/jcm12237212.</mixed-citation><mixed-citation xml:lang="en">Napoli G., Pergola V., Basile P., De Feo D., Bertrandino F., Baggiano A. et al. Epicardial and Pericoronary Adipose Tissue, Coronary Inflammation, and Acute Coronary Syndromes. J. Clin. Med. 2023 21;12(23):7212. DOI: 10.3390/jcm12237212.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Song Y., Tan Y., Deng M., et al. Epicardial adipose tissue, metabolic disorders, and cardiovascular diseases: recent advances classified by research methodologies. MedComm. 2023;4:e413. DOI: 10.1002/mco2.413.</mixed-citation><mixed-citation xml:lang="en">Song Y., Tan Y., Deng M., et al. Epicardial adipose tissue, metabolic disorders, and cardiovascular diseases: recent advances classified by research methodologies. MedComm. 2023;4:e413. DOI: 10.1002/mco2.413.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kologrivova, I.V, Naryzhnaya N.V., Koshelskaya O.A., Suslova T.E., Kravchenko E.S., Kharitonova O.A., Evtushenko V.V., Boshchenko A.A. Association of Epicardial Adipose Tissue Adipocytes Hypertrophy with Biomarkers of Low-Grade Inflammation and Extracellular Matrix Remodeling in Patients with Coronary Artery Disease. Biomedicines. 2023:17;11(2):241. DOI: 10.3390/biomedicines11020241.</mixed-citation><mixed-citation xml:lang="en">Kologrivova, I.V, Naryzhnaya N.V., Koshelskaya O.A., Suslova T.E., Kravchenko E.S., Kharitonova O.A., Evtushenko V.V., Boshchenko A.A. Association of Epicardial Adipose Tissue Adipocytes Hypertrophy with Biomarkers of Low-Grade Inflammation and Extracellular Matrix Remodeling in Patients with Coronary Artery Disease. Biomedicines. 2023:17;11(2):241. DOI: 10.3390/biomedicines11020241.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Sivasami P., Li C. Derivation and Differentiation of Adipose-Tissue Regulatory T Cells: A Stepwise, Multi-Site Process. Front. Immunol. 2020;11:599277. DOI: 10.3389/fimmu.2020.599277.</mixed-citation><mixed-citation xml:lang="en">Sivasami P., Li C. Derivation and Differentiation of Adipose-Tissue Regulatory T Cells: A Stepwise, Multi-Site Process. Front. Immunol. 2020;11:599277. DOI: 10.3389/fimmu.2020.599277.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Palatella M., Guillaume S.M., Linterman M.A., Huehn J. The dark side of Tregs during aging. Front Immunol. 2022;13:940705. DOI: 10.3389/fimmu.2022.940705</mixed-citation><mixed-citation xml:lang="en">Palatella M., Guillaume S.M., Linterman M.A., Huehn J. The dark side of Tregs during aging. Front Immunol. 2022;13:940705. DOI: 10.3389/fimmu.2022.940705</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Yu Y., Bai H., Wu F., Chen J., Li B., Li Y.. Tissue adaptation of regulatory T cells in adipose tissue. Eur J Immunol. 2022;52(12):1898-1908. DOI: 10.1002/eji.202149527.</mixed-citation><mixed-citation xml:lang="en">Yu Y., Bai H., Wu F., Chen J., Li B., Li Y.. Tissue adaptation of regulatory T cells in adipose tissue. Eur J Immunol. 2022;52(12):1898-1908. DOI: 10.1002/eji.202149527.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Magg T., Mannert J., Ellwart J.W., Schmid I., Albert M.H. Subcellular localization of FOXP3 in human regulatory and nonregulatory T cells. Eur J Immunol. 2012;42(6):1627-38. DOI: 10.1002/eji.201141838.</mixed-citation><mixed-citation xml:lang="en">Magg T., Mannert J., Ellwart J.W., Schmid I., Albert M.H. Subcellular localization of FOXP3 in human regulatory and nonregulatory T cells. Eur J Immunol. 2012;42(6):1627-38. DOI: 10.1002/eji.201141838.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lemarquis A.L.L., Kousa A., Argyropoulos K.V., Jahn L., Gipson B., Serrano-Marin L., Andrlova H., Tsai J., Dudakov J.A., DeWolf S., Brink M.; Recirculating Regulatory T Cells Mediate Thymic Regeneration in a ZFP36L1 and Amphiregulin Dependent Manner. Blood 2023; 142 (Supplement 1): 457. DOI: 10.1182/blood-2023-183036.</mixed-citation><mixed-citation xml:lang="en">Lemarquis A.L.L., Kousa A., Argyropoulos K.V., Jahn L., Gipson B., Serrano-Marin L., Andrlova H., Tsai J., Dudakov J.A., DeWolf S., Brink M.; Recirculating Regulatory T Cells Mediate Thymic Regeneration in a ZFP36L1 and Amphiregulin Dependent Manner. Blood 2023; 142 (Supplement 1): 457. DOI: 10.1182/blood-2023-183036.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Кологривова И.В., Суслова Т.Е., Кошельская О.А., Харитонова О.А., Трубачева О.А., Кравченко Е.С. Циркулирующие FoxP3+ Т-лимфоциты при хронической ишемической болезни сердца: взаимосвязь с тяжестью атеросклероза и состоянием обмена липидов. Сибирский журнал клинической и экспериментальной медицины. 2021;36(2):45-51.</mixed-citation><mixed-citation xml:lang="en">Kologrivova I.V., Suslova T.E., Koshelskaya O.A., Kharitonova O.A., Trubacheva O.A., Kravchenko E.S. Circulating FoxP3+ T-lymphocytes in chronic coronary artery disease: Associations with the severity of atherosclerosis and lipid metabolism. The Siberian Journal of Clinical and Experimental Medicine. 2021;36(2):45–51. DOI: 10.29001/2073-8552-2021-36- 2-45-51.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kologrivova I.V., Suslova T.E., Koshelskaya O.A., Kharitonova O.A., Trubacheva O.A., Kravchenko E.S. Circulating FoxP3+ T-lymphocytes in chronic coronary artery disease: Associations with the severity of atherosclerosis and lipid metabolism. The Siberian Journal of Clinical and Experimental Medicine. 2021;36(2):45–51. DOI: 10.29001/2073-8552-2021-36- 2-45-51.</mixed-citation><mixed-citation xml:lang="en">Charaix J., Borelli A., Santamaria J.C., Chasson L., Giraud M., Sergé A., Irla M. Recirculating Foxp3+ regulatory T cells are restimulated in the thymus under Aire control. Cell Mol Life Sci. 2022;79(7):355. DOI: 10.1007/s00018-022-04328-9.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Charaix J., Borelli A., Santamaria J.C., Chasson L., Giraud M., Sergé A., Irla M. Recirculating Foxp3+ regulatory T cells are restimulated in the thymus under Aire control. Cell Mol Life Sci. 2022;79(7):355. DOI: 10.1007/s00018-022-04328-9.</mixed-citation><mixed-citation xml:lang="en">Dooley J., Liston A. Molecular control over thymic involution: from cytokines and microRNA to aging and adipose tissue. Eur J Immunol. 2012;42(5):1073-9. DOI: 10.1002/eji.201142305.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Dooley J., Liston A. Molecular control over thymic involution: from cytokines and microRNA to aging and adipose tissue. Eur J Immunol. 2012;42(5):1073-9. DOI: 10.1002/eji.201142305.</mixed-citation><mixed-citation xml:lang="en">Kozlov V.A. Determining role of thymus in immune pathogenesis of autoimmune, oncological and infectious diseases. Medical Immunology (Russia). 2023;25(1):39–58. (In Russ.). DOI: 10.15789/1563-0625-DRO-2591.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Козлов В.А. Определяющая роль тимуса в иммунопатогенезе аутоиммунных, онкологических и инфекционных заболеваний. Медицинская иммунология. 2023;25(1):39-58.</mixed-citation><mixed-citation xml:lang="en">Dai X., Zhang D., Wang C. et al. The Pivotal Role of Thymus in Atherosclerosis Mediated by Immune and Inflammatory Response. Int J Med Sci. 2018 20;15(13):1555-1563. DOI: 10.7150/ijms.27238.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Dai X., Zhang D., Wang C. et al. The Pivotal Role of Thymus in Atherosclerosis Mediated by Immune and Inflammatory Response. Int J Med Sci. 2018 20;15(13):1555-1563. DOI: 10.7150/ijms.27238.</mixed-citation><mixed-citation xml:lang="en">Palatella M., Guillaume S.M., Linterman M.A. et al The dark side of Tregs during aging. Front. Immunol. 2022;13:940705. DOI: 10.3389/fimmu.2022.940705</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Palatella M., Guillaume S.M., Linterman M.A. et al The dark side of Tregs during aging. Front. Immunol. 2022;13:940705. DOI: 10.3389/fimmu.2022.940705</mixed-citation><mixed-citation xml:lang="en">Thiault N., Darrigues J., Adoue V., Gros M., Binet B., Perals C., Leobon B., Fazilleau N., Joffre O.P., Robey E.A., van Meerwijk J.P.M., Romagnoli P. Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors. Nat. Immunol. 2015;16(6):628-34. DOI: 10.1038/ni.3150.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Thiault N., Darrigues J., Adoue V., Gros M., Binet B., Perals C., Leobon B., Fazilleau N., Joffre O.P., Robey E.A., van Meerwijk J.P.M., Romagnoli P. Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors. Nat. Immunol. 2015;16(6):628-34. DOI: 10.1038/ni.3150.</mixed-citation><mixed-citation xml:lang="en">Rueda C.M., Rodríguez-Perea A.L., Moreno-Fernandez M., Jackson C.M., Melchior J.T., Davidson W.S., Chougnet C.A. High density lipoproteins selectively promote the survival of human regulatory T cells. J Lipid Res. 2017;58(8):1514-1523. DOI: 10.1194/jlr.M072835.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Rueda C.M., Rodríguez-Perea A.L., Moreno-Fernandez M., Jackson C.M., Melchior J.T., Davidson W.S., Chougnet C.A. High density lipoproteins selectively promote the survival of human regulatory T cells. J Lipid Res. 2017;58(8):1514-1523. DOI: 10.1194/jlr.M072835.</mixed-citation><mixed-citation xml:lang="en">Atehortua L., Davidson W.S., Chougnet C.A. Interactions Between HDL and CD4+ T Cells: A Novel Understanding of HDL Anti-Inflammatory Properties. Arterioscler Thromb Vasc Biol. 2024;44(6):1191-1201. DOI: 10.1161/ATVBAHA.124.320851.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Atehortua L., Davidson W.S., Chougnet C.A. Interactions Between HDL and CD4+ T Cells: A Novel Understanding of HDL Anti-Inflammatory Properties. Arterioscler Thromb Vasc Biol. 2024;44(6):1191-1201. DOI: 10.1161/ATVBAHA.124.320851.</mixed-citation><mixed-citation xml:lang="en">Saravia J., Zeng H., Dhungana Y., Bastardo Blanco D., Nguyen T.M., Chapman N.M., Wang Y., Kanneganti A., Liu S., Raynor J.L., Vogel P., Neale G., Carmeliet P., Chi H. Homeostasis and transitional activation of regulatory T cells require c-Myc. Sci Adv. 2020;6(1):eaaw6443. DOI: 10.1126/sciadv.aaw6443.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Saravia J., Zeng H., Dhungana Y., Bastardo Blanco D., Nguyen T.M., Chapman N.M., Wang Y., Kanneganti A., Liu S., Raynor J.L., Vogel P., Neale G., Carmeliet P., Chi H. Homeostasis and transitional activation of regulatory T cells require c-Myc. Sci Adv. 2020;6(1):eaaw6443. DOI: 10.1126/sciadv.aaw6443.</mixed-citation><mixed-citation xml:lang="en">Saravia J., Zeng H., Dhungana Y., Bastardo Blanco D., Nguyen T.M., Chapman N.M., Wang Y., Kanneganti A., Liu S., Raynor J.L., Vogel P., Neale G., Carmeliet P., Chi H. Homeostasis and transitional activation of regulatory T cells require c-Myc. Sci Adv. 2020;6(1):eaaw6443. DOI: 10.1126/sciadv.aaw6443.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
